Posted in

Pioneering Pediatric Transplant Saves Girl with Rare Syndrome

•Posted inMedical Updates
Indian doctor preparing for the USMLE exam with study materials and practice exams

Pioneering Pediatric Transplant Saves Girl with Rare Syndrome

MGM Cancer Institute recently achieved a significant medical milestone. They performed the world’s first successful pediatric bone marrow transplant for a 12-year-old girl with Bloom Syndrome. This rare genetic disorder involves bone marrow failure and a heightened cancer risk. The innovative procedure used a TCR alpha beta depleted haploidentical bone marrow transplant. Stem cells came from the patient’s younger brother. Doctors confirm the patient, also diagnosed with Monosomy 7 and Myelodysplastic Syndrome (MDS), is thriving. [2, 3, 8]

The Complexity of Bloom Syndrome and Co-existing Conditions

Bloom Syndrome is an exceedingly rare genetic condition. Furthermore, this patient’s case was complicated by two additional severe diagnoses: Monosomy 7 and Myelodysplastic Syndrome (MDS). [2] Monosomy 7 is a chromosomal abnormality, while MDS involves the bone marrow failing to produce healthy blood cells. [2, 19] The combination of these conditions is remarkably uncommon; only a handful of such cases have been documented globally. [2] Without effective treatment, MDS carries a high risk of progressing to leukemia, which clearly made the transplant both urgent and essential for this young girl. [2, 6]

Finding a Suitable Donor and Adapting Protocols for Pediatric Bone Marrow Transplant

Finding a suitable donor presented a significant challenge. No fully matched family or unrelated donors existed. Both parents carried the genetic mutation, which complicated their donor suitability. [2, 8] Following careful genetic evaluation, doctors identified her younger brother as a viable donor because he did not carry the mutation. [2] His younger age and lower body weight, however, compelled modifications to the stem cell collection process. This ensured a safe yet sufficient stem cell harvest. [2, 5] Furthermore, the team adapted the transplant conditioning protocol. Children with Bloom Syndrome are highly sensitive to chemotherapy; consequently, they cannot tolerate standard regimens. [2, 8] Therefore, precise, customized treatment plans were essential.

The Pediatric Bone Marrow Transplant Procedure

The multidisciplinary team at MGM Cancer Institute, led by Dr. M. Deenadayalan, Head and Clinical Lead of Paediatric Haematology, Oncology, Blood and Marrow Transplantation, successfully performed the transplant. [2] This specialized TCR alpha beta depleted haploidentical bone marrow transplant removes specific T-cells and B-cells from the donor’s graft. These cells often cause graft-versus-host disease (GVHD), thereby minimizing transplant complications. [4, 10, 11] The technique retains other crucial immune cells that aid in engraftment and provide anti-infective activity. [4, 16] This approach is especially beneficial when fully matched donors are unavailable. [10] Following the transplant, the patient has made an excellent recovery. [3] She has returned to school and participates in daily activities, demonstrating full immunological recovery. [3, 5] She will continue under medical follow-up to monitor her long-term health.

Global Recognition and Future Implications

This complex case has garnered significant attention. The outcome was successful. The case, indeed, appeared in Pediatric Blood and Cancer, a respected peer-reviewed journal for pediatric hematology and oncology. [3, 18] Dr. M. Deenadayalan highlighted the rarity and complexity. He stated, “Bloom Syndrome is a rare genetic disorder. Here, Monosomy 7 and Myelodysplastic Syndrome further complicated it. This combination is so uncommon that only a handful of such cases have been reported globally.” [3] The patient’s excellent recovery, with full immunological recovery and 100% donor chimerism, confirms the transplant’s success. [3] This achievement marks the world’s only documented successful TCR alpha beta depleted haploidentical bone marrow transplant in a child with Bloom Syndrome. [3] This pioneering effort offers immense hope for children worldwide facing similar exceptionally rare and complex conditions.

Frequently Asked Questions

Q1: What is Bloom Syndrome and why is a bone marrow transplant necessary for it?

Bloom Syndrome is a rare genetic disorder characterized by short stature, sun sensitivity, and a high risk of developing cancers, including those affecting the bone marrow. Bone marrow failure and the potential progression of associated conditions like Myelodysplastic Syndrome (MDS) to leukemia make a bone marrow transplant a critical, often life-saving, treatment option. [2, 3]

Q2: What is a TCR alpha beta depleted haploidentical bone marrow transplant?

This is a specialized type of bone marrow transplant where the donor is only a “half-match” (haploidentical), typically a parent or sibling. Crucially, specific T-cells (alpha beta T-cells) and B-cells from the donor’s stem cell graft are removed. This process significantly reduces the risk of graft-versus-host disease (GVHD) while preserving other beneficial immune cells. [4, 10, 11]

Q3: Why was this specific pediatric transplant considered a world’s first?

This particular transplant was the first documented successful TCR alpha beta depleted haploidentical bone marrow transplant performed on a child specifically diagnosed with Bloom Syndrome, Monosomy 7, and Myelodysplastic Syndrome. The combination of these rare conditions, coupled with the specialized transplant technique and the successful long-term outcome, makes it a unique global achievement. [3, 8]

References

  1. MGM Cancer Institute Performs World’s First Successful Pediatric Bone MarrowTransplant for Bloom Syndrome – ETHealthworld
  2. Girl with rare genetic disorder undergoes bone marrow transplant at Chennai hospital. Vertex AI Search. Retrieved from [https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGhCOaJmKFp8-mhQ4N2INngzuwy58bVpGFVO0KB1exJaCemMdV8Cmg4AyGjYVBgE2Vi9ztERC2NLoVnPltYBrDgliyYw7Kg-fBmKWsZgE2kV9-P5sNpCmN5BawLl_c2kBKzgecqBlWiuhBgul9zE-ZWJgboVjuCFBsaR0iEMkp1bcCYykujmUtDncrhSkVQBRiCMuKzkmjorwd02o7_Zcpem9wqiLVvW3fuyBHWgRJmE02aVR7HES7htBumNp4gQfRiE9u4Dk24paAiCyhVdMyG]
  3. MGM Cancer Institute Achieves World’s First Half-Matched Transplant In Bloom Syndrome Child With Chromosomal, Marrow Complications. TRIPURA STAR NEWS. Retrieved from [https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFYC6mbaSEp5UYcOIB0BhENRkD38TB-yR4BVnzJz1yivgJJEK7O-qPV6AjLLFeZxvlJVphvwvjhEWgrHHDFiiOWjt-vVHmo2fONLVgLzREX90oIZyqcLpAYGBRlVRksT0Gd7Qddrbzvk6QBLLfg6i0xXppGxD-Jt7RuEod3CjylDyYICLdZvcy8kzhSbtoUyTrccTLaLkiXOkZONHsx7dCK-WWwZ1X4K4ZDBoJCe2OSCqBNHqseFlT3qlmJMWo_ZHnLCmJtHWt5XZA5Y018kI8fjaCOgEwyfCaLW1u_]
  4. TCR αβ+/CD19+ cell depletion in haploidentical hematopoietic allogeneic stem cell transplantation: a review of current data – PubMed. Retrieved from [https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHCwXCQJRCgTujhPxALHYD-QN30iZlnRnhsI5d7y1vbBxpKy9rk4goz_Vxx6r1irl98NuQnmuxBmayIwjdw71Up-ARLC0FtzDcR8XKSHAuhv6rT14f93WzSFj4IQrU3PYIOB_8=]
  5. MGM Cancer Institute Achieves World’s First Half-Matched Transplant in Bloom Syndrome Child – YouTube. Retrieved from [https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGHLuHICbjFU0n_zIQnmYmHCIGdOViWTZ26Ctl3KF87Dk6KthxkeQdbRbwlesEjzwzShtXgsxlf9A2ExSh2cR9-uU7WbHJY2EupyfoXnvMxbk3Szzbqzg==]
  6. How I treat myelodysplastic syndromes of childhood | Blood | American Society of Hematology. Retrieved from [https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHrFkcFNnDD6SPde2OZBj5nwfvkSkVPeXHSI322glmdZ23pg4uweUsJWj2X4UHPamyDnGnCRsVrBU82eLR41ZQYBAdKLKJZiJ5wVCvgPfoE13KaoU9sUmltG1_A24_NfIIJ8PxYszmQhmexDmRr0LZ4lDo4tArUptPe7rsDCNAw2wq2zZ-_YwkrQFkPhIckCSSKUMm1AyC-5F39IDPimA-jJ8AgadGalBk=]
  7. MGM Cancer Institute Achieves World’s First Half-Matched Transplant in Bloom Syndrome Child – YouTube. Retrieved from [https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG3iUncIYaT5hkIJkvkNN1jpUrvXqatwJmjyLOptKpQWYak4_F-jfoGdhsSoRB82y900OWMcLclZEnb61HM5pZKegd5427qW32NgEy6Q1OOz-4-VwdJN2e6rBlqYBmSrp3YeAb2EQ==]
  8. Rare Pediatric Transplant for Bloom Syndrome Case Completed at MGM Cancer Institute. Retrieved from [https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGC7ML5prVsiXwBKSE0U1oNtoI7cc0s7AOaKwl3oqKhgR5NetPyepS8QX6HwC2EPpoMDIZ_9wUM2S_cyI_ni-A_7a2uzbP7p4wYR-FhY-E7mwIswfR3sGqSSf3E5Sp4J47LQaeWkxRem5PA2QS3rDp1dlwrohCnxgYcIvOmLkSY_9a3l5qTxKFFgGD45_j5gQ_fIC-1QQzfGJ8MbQfR5AuznoFIXCChgv0Lm_Oc_c6lKELXkqjQacvC417VNqVhDdYXvtAcB_fI-Wh5DBNQ4tGakf5L3KTevg==]
  9. TCR αβ/CD19 cell–depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis | Blood | American Society of Hematology. Retrieved from [https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG0GiYXWzocAdA4Z5BZkeW15bqpijopnX0xLTpv4LpVeG1yLIf8Frc5BkLpl3a_CVyXLnXbd-2Y2K1hWT1M6bH-F-iMKWnFnfvSL8PTzB5FWWKg-0hJyyNrxa9Bch3qgALZLb9DXDh50rdAA3XFPCrd-E2Usx2BICaa1HorEkMqn2uX6O4AGMMIklcPYVLXnHYV4eVRhB7KUf4midYquw==]
  10. Haploidentical Stem Cell Transplantation After TCR-αβ+ and CD19+ Cells Depletion In Children With Congenital Non-Malignant Disease – PubMed. Retrieved from [https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQG2pB5IoUR_HVevyhWUkm-Xkn4t8UNIw419agQ6dfwaz8i9HnbUPYcAzaNy_7xCC3HF7ONFFi1ya23u6jFCJN1KXZZMZ9fOepzIwkKB1lZI0COHWmNNLAqQ9G4RduaMLXH_W6g==]
  11. TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders | Blood Advances | American Society of Hematology. Retrieved from [https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHfap-LfC4-KruJXyrf8BAvfbyFZ8KaQR943Hi_57JwGsmVsXfof_CgMRJwoyWAp88j-i-WnqjYlo6mTo5PT15zRnypMZVUn_kmVehdwU-eUsUj1BxqneQFRsrMT8OtsIQEslo3xjt0zSybtRH14jax_8MmNXe0ERca7s7IETVC-HVgfcYc2ygEbrZ-Z9RAPB5XN6bjxeO0BKxbCgp-0lFn6TNwdAuns_mNmzIm]
  12. Successful Haploidentical Haematopoietic Stem Cell Transplant in a Rare Case of Bloom Syndrome Associated With Monosomy 7/MDS – PubMed. Retrieved from [https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGAaqBlS8oZ91IFl8qqR3GXFEINcIOmSKGX1ZMRbzTcOHN3ct5gNyc1R6yUmKh4CEKqROCpMItP-BE0adtzzmbmjgswcfTjzQiMwYbSIjY1tEnvATJnqi0SZmg8_hAeHngAwvQ=]
  13. Monosomy 7 in Pediatric Myelodysplastic Syndromes – PubMed. Retrieved from [https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQExMCq3SRLiZwmT8Qy_dP7tGNfrTFLNlmxW3-qdrcXWcm7lrmQPr6JOUJSNIIbsH65Rc3SdqUV3lH-CsrlInbzNCF9lm4I3u-jsoMrSmEmicVcoEA95B23fdLMLfLnI6LYiJek=]

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.